Share Share on Facebook Share on Twitter Pinterest Email Radiopharm Theranostics (RAD:AU) has announced First patient dosed in Phase IIb imaging for Brain Mets Download the PDF here. This post appeared first on investingnews.com Related Posts RHI: Acqn of royalty over Sandstone Gold Project tenements April 28, 2025 Binding Commitments Received for A$1.0 Million under Convertible Note Placement April 28, 2025 Crypto Market Recap: ARK Invest Calls for Bitcoin Price of US$2.4 Million by 2030 April 27, 2025